close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Bristol/Myers Squibb Co

Recent news which mentions Bristol/Myers Squibb Co

< Previous 1 2 3 4 Next >
Trump's drug price ultimatum sets pharma firms scrambling
Tags Pharmaceuticals Bristol/Myers Squibb Co Amgen Inc
From CNBC.com News
Pandemic darlings Moderna, BioNTech are now on two different paths
Tags Biotech and Pharmaceuticals Health & Science Biontech SE
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags AstraZeneca PLC Health & Science Roche Holding AG
From CNBC.com News
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
Tags Pharmaceuticals Bristol/Myers Squibb Co Companies
From CNBC.com News
Cramer's Lightning Round: 'You can speculate with' CleanSpark
Tags Markets stocks Investment Strategy
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Bristol/Myers Squibb Co Health care industry Social issues
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags GSK plc Biontech SE Gilead Sciences Inc
From CNBC.com News
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Tags Amazon/com Inc AstraZeneca PLC Health & Science
From CNBC.com News
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
Tags Biotech and Pharmaceuticals Health & Science Merck & Co Inc
From CNBC.com News
Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know
Tags Gilead Sciences Inc Business LILLY DRN
From CNBC.com News
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
Tags Biotech and Pharmaceuticals Breaking News: Business Earnings
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Healthy Returns Centene Corp Bristol/Myers Squibb Co
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Biotech and Pharmaceuticals Breaking News: Business Merck & Co Inc
From CNBC.com News
Jim Cramer says investors should follow the post-dot-com-bubble playbook
Tags Investment strategy Lockheed Martin Corp Business
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Bristol/Myers Squibb Co Pro: Investing trends Moderna Inc
From CNBC.com News
Cramer's Lightning Round: Deere is a buy
Tags stocks Markets Mad Money
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Companies Health care industry Social issues
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Advanced Micro Devices Inc Investing Amazon/com Inc
From CNBC.com News
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
Tags Pfizer Inc Business Earnings
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Markets General Motors Co Technology
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Advanced Micro Devices Inc Spotify Technology SA Chipotle Mexican Grill Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Breaking News: Business Biotech and Pharmaceuticals Teva Pharmaceutical Industries Ltd
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Biotech and Pharmaceuticals Business LILLY DRN
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Amgen Inc Iovance Biotherapeutics Inc Waystar Holding Corp
From CNBC.com News
Bristol Myers Squibb CEO describes new drug for treating schizophrenia
Tags Stock Picks Bristol/Myers Squibb Co Business News
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Health care industry Social issues Bristol/Myers Squibb Co
From CNBC.com News
Here are our top 10 things to watch in the stock market Monday
Tags Mitsubishi Corp CNBC Investing Club: Cramer’s Morning Thoughts Investment strategy
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags LILLY DRN Healthy Returns Novartis AG
From CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
Tags Investment Strategy Mad Money stocks
From CNBC.com News
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Tags Breaking news Earnings Breaking News: Business
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today